These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 14737832)

  • 1. [Angiotensin II receptor].
    Horiuchi M
    Nihon Rinsho; 2004 Jan; 62(1):29-36. PubMed ID: 14737832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent progress in AT1 and AT2 receptor research].
    Horiuchi M
    Nihon Rinsho; 2002 Oct; 60(10):1873-80. PubMed ID: 12397677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.
    Masaki H; Kurihara T; Yamaki A; Inomata N; Nozawa Y; Mori Y; Murasawa S; Kizima K; Maruyama K; Horiuchi M; Dzau VJ; Takahashi H; Iwasaka T; Inada M; Matsubara H
    J Clin Invest; 1998 Feb; 101(3):527-35. PubMed ID: 9449684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
    Carnovali M
    Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathophysiological function of angiotensin II AT1 and AT2 receptors and clinical application of AT1 antagonists].
    Matsubara H; Mori Y; Masaki H; Inada M
    Nihon Rinsho; 1998 Jul; 56(7):1912-8. PubMed ID: 9702075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts.
    van Kesteren CA; van Heugten HA; Lamers JM; Saxena PR; Schalekamp MA; Danser AH
    J Mol Cell Cardiol; 1997 Aug; 29(8):2147-57. PubMed ID: 9281446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II effects on second messengers involved in prolactin secretion are mediated by AT1 receptor in anterior pituitary cells.
    Moreau C; Rasolonjanahary R; Audinot V; Kordon C; Enjalbert A
    Mol Cell Neurosci; 1994 Dec; 5(6):597-603. PubMed ID: 7704434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain and peripheral angiotensin II type 1 receptors mediate renal vasoconstrictor and blood pressure responses to angiotensin IV in the rat.
    Yang R; Smolders I; De Bundel D; Fouyn R; Halberg M; Demaegdt H; Vanderheyden P; Dupont AG
    J Hypertens; 2008 May; 26(5):998-1007. PubMed ID: 18398343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variety of angiotensin receptors in 3T3-L1 preadipose cells and differentiated adipocytes.
    Weiland F; Verspohl EJ
    Horm Metab Res; 2008 Nov; 40(11):760-6. PubMed ID: 18711690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AT2-antagonist sensitive potentiation of angiotensin II-induced vasoconstrictions by blockade of nitric oxide synthesis in rat renal vasculature.
    Muller C; Endlich K; Barthelmebs M; Helwig JJ
    Br J Pharmacol; 1997 Dec; 122(7):1495-501. PubMed ID: 9421301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II--receptor subtypes characterization and pathophysiological implications.
    Gulati K; Lall SB
    Indian J Exp Biol; 1996 Feb; 34(2):91-7. PubMed ID: 8641721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologic and pharmacologic implications of AT1 versus AT2 receptors.
    Chung O; Stoll M; Unger T
    Blood Press Suppl; 1996; 2():47-52. PubMed ID: 8913540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass-spectrometric identification of a novel angiotensin peptide in human plasma.
    Jankowski V; Vanholder R; van der Giet M; Tölle M; Karadogan S; Gobom J; Furkert J; Oksche A; Krause E; Tran TN; Tepel M; Schuchardt M; Schlüter H; Wiedon A; Beyermann M; Bader M; Todiras M; Zidek W; Jankowski J
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):297-302. PubMed ID: 17138938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathophysiological roles of angiotensin in the pathogenesis of hypertension and cardiovascular remodeling].
    Horiuchi M
    Rinsho Byori; 2000 Oct; 48(10):935-40. PubMed ID: 11215107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin IV activates the nuclear transcription factor-kappaB and related proinflammatory genes in vascular smooth muscle cells.
    Esteban V; Ruperez M; Sánchez-López E; Rodríguez-Vita J; Lorenzo O; Demaegdt H; Vanderheyden P; Egido J; Ruiz-Ortega M
    Circ Res; 2005 May; 96(9):965-73. PubMed ID: 15831814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Angiotensin II receptor-mediated function unmasked by gene-engineered animals].
    Matsubara H; Iwasaka T
    Nihon Rinsho; 1999 May; 57(5):1084-9. PubMed ID: 10361439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system.
    Horiuchi M; Akishita M; Dzau VJ
    Hypertension; 1999 Feb; 33(2):613-21. PubMed ID: 10024316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensins II and IV stimulate the rat adrenocortical cell proliferation acting via different receptors.
    Pawlikowski M; Gruszka A; Mucha S; Melen-Mucha G
    Endocr Regul; 2001 Sep; 35(3):139-42. PubMed ID: 11674842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of angiotensin receptor subtypes in cerebrovascular regulation in the rat.
    Näveri L
    Acta Physiol Scand Suppl; 1995; 630():1-48. PubMed ID: 8610501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.